AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33619983 — intervention group
Group type: COMPARATOR
Intervention: Splint-less (preterms)
Number of subjects: 159
Study 33619983 — intervention group
Group type: EXPERIMENTAL
Intervention: Splint (across joints)
Number of subjects: 159
Study 33619983 — intervention group
Group type: COMPARATOR
Intervention: Splint-less (across joints)
Number of subjects: 159
Study 34595577 — intervention group
Group type: COMPARATOR
Intervention: Autogenous bone graft from the zygomatic buttress (Control)
Number of subjects: 60
Study 34595577 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:1 mixture of autogenous bone graft and deproteinized porcine bone mineral (DPBM) (Test I)
Number of subjects: 60
Study 34595577 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic bone graft material (BBGM) (Test II)
Number of subjects: 60
Study 32847127 — intervention group
Group type: EXPERIMENTAL
Intervention: Microprocessor knee 1
Number of subjects: 20
Study 32847127 — intervention group
Group type: EXPERIMENTAL
Intervention: Microprocessor knee 2
Number of subjects: 20
Study 32847127 — intervention group
Group type: COMPARATOR
Intervention: Comparison between microprocessor knee 1 and microprocessor knee 2
Number of subjects: 20
Study 33301569 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency deep brain stimulation (DBS) at randomized different intensities
Number of subjects: 16
Study 33301569 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency deep brain stimulation (DBS)
Number of subjects: 16
Study 32493398 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate closure (VenaSeal™ closure system)
Number of subjects: 0
Study 32493398 — intervention group
Group type: COMPARATOR
Intervention: Surgical stripping
Number of subjects: 0
Study 32493398 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 0
Study 35788212 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacutaneous fibrolysis
Number of subjects: 66
Study 35788212 — intervention group
Group type: COMPARATOR
Intervention: Control limb (no treatment)
Number of subjects: 66
Study 34251142 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of telephone protocol
Number of subjects: 2498
Study 34251142 — intervention group
Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 2498
Study 32219497 — intervention group
Group type: EXPERIMENTAL
Intervention: Metha (B‐Braun)
Number of subjects: 36
Study 32219497 — intervention group
Group type: EXPERIMENTAL
Intervention: SMF (Smith and Nephew)
Number of subjects: 36
Study 35766592 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg propofol (group P)
Number of subjects: 102
Study 35766592 — intervention group
Group type: COMPARATOR
Intervention: 1 mg/kg lidocaine 2% (group L)
Number of subjects: 102
Study 33041226 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 765
Study 35919499 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group (50 patients) treated with Clostridium caseinate bifidobacterial probiotics
Number of subjects: 100
Study 35919499 — intervention group
Group type: COMPARATOR
Intervention: Traditional group (50 patients) receiving conventional treatment
Number of subjects: 100
Study 34050539 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian approach for sequentially monitoring phase II randomized clinical trials with noncompliance information.
Number of subjects: 0
Study 34050539 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian additive regression trees for selecting baseline covariates and estimating complier average causal effect (CACE).
Number of subjects: 0
Study 34050539 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision-making based on estimated CACE from accumulated data.
Number of subjects: 0
Study 32819331 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) program covering six techniques in 4 sessions (30 min each), with or without pharmacotherapy.
Number of subjects: 0
Study 32819331 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail, but implied to be standard care or pharmacotherapy).
Number of subjects: 0
Study 34850095 — intervention group
Group type: EXPERIMENTAL
Intervention: peficitinib
Number of subjects: 1052
Study 33372675 — intervention group
Group type: EXPERIMENTAL
Intervention: tBRCA testing
Number of subjects: 1176
Study 33372675 — intervention group
Group type: COMPARATOR
Intervention: gBRCA testing
Number of subjects: 1176
Study 33156076 — intervention group
Group type: EXPERIMENTAL
Intervention: Microthin Descemet stripping automated endothelial keratoplasty (MT‐DSAEK)
Number of subjects: 56
Study 33156076 — intervention group
Group type: COMPARATOR
Intervention: Descemet membrane endothelial keratoplasty (DMEK)
Number of subjects: 56
Study 33156076 — intervention group
Group type: COMPARATOR
Intervention: Both groups (MT‐DSAEK and DMEK)
Number of subjects: 56
Study 35082179 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-grooved treatment
Number of subjects: 240
Study 35082179 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfuric-acid-etched treatment
Number of subjects: 240
Study 35082179 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 240
Study 35082179 — intervention group
Group type: COMPARATOR
Intervention: Sandblasted treatment
Number of subjects: 240
Study 34733185 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Assisted Relaxation (MAR) protocol, a music therapy technique composed of entrained live music combined with a guided relaxation and/or the use of imagery
Number of subjects: 81
Study 34733185 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 81
Study 34733185 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Assisted Relaxation (MAR) protocol
Number of subjects: 81
Study 36119100 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 0
Study 36119100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35801801 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sulfate tablet (OST)
Number of subjects: 179
Study 35801801 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG)
Number of subjects: 179
Study 34140456 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring-supported exercise training for 6 months
Number of subjects: 314
Study 34140456 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 314
Study 32643857 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg)
Number of subjects: 12637
Study 32643857 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide (0.5-1.0 mg)
Number of subjects: 12637
Study 32643857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12637
Study 35799662 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginoscopy
Number of subjects: 125
Study 35799662 — intervention group
Group type: COMPARATOR
Intervention: Conventional Hysteroscopy
Number of subjects: 125
Study 33906741 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban children
Number of subjects: 557
Study 33906741 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural children
Number of subjects: 557
Study 33906741 — intervention group
Group type: COMPARATOR
Intervention: Rural households cooking outside
Number of subjects: 557
Study 33906741 — intervention group
Group type: COMPARATOR
Intervention: Rural households supervising older children
Number of subjects: 557
Study 33588633 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Schools Healthy Communities (HSHC) initiative
Number of subjects: 0
Study 32157599 — intervention group
Group type: EXPERIMENTAL
Intervention: DB-020 (sodium thiosulfate pentahydrate in 1% sodium hyaluronate) administered via intratympanic injection
Number of subjects: 5
Study 35121623 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib plus Fulvestrant
Number of subjects: 669
Study 35121623 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus Fulvestrant
Number of subjects: 669
Study 32080811 — intervention group
Group type: EXPERIMENTAL
Intervention: 650 mg of PL-ASA in fasted state
Number of subjects: 20
Study 32080811 — intervention group
Group type: COMPARATOR
Intervention: 650 mg of PL-ASA in fed state
Number of subjects: 20
Study 35946981 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin 0.05% lotion (Altreno)
Number of subjects: 25
Study 35946981 — intervention group
Group type: COMPARATOR
Intervention: Generic 0.05% cream
Number of subjects: 25
Study 35337317 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective Structured Clinical Examination (OSCE) assessment method for Kampo medicine
Number of subjects: 11
Study 32350185 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 5% zinc oxide paste, applied trice daily after food for the entire treatment period, initiated 2 days prior to radiotherapy.
Number of subjects: 75
Study 32350185 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvised zinc preparation (1%), applied trice daily after food for the entire treatment period, initiated 2 days prior to radiotherapy.
Number of subjects: 75
Study 32350185 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvised zinc preparation (1%)
Number of subjects: 75
Study 32350185 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment offered by cancer hospital (Control group)
Number of subjects: 75
Study 33775047 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial intelligence prediction model for inherited metabolic diseases
Number of subjects: 5907547
Study 33775047 — intervention group
Group type: COMPARATOR
Intervention: Clinicians' detection
Number of subjects: 5907547
Study 33775047 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial intelligence prediction model
Number of subjects: 5907547
Study 33775047 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial intelligence model
Number of subjects: 5907547
Study 36062848 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy
Number of subjects: 116
Study 36062848 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilemma‐focused therapy
Number of subjects: 116
Study 36062848 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 116
Study 34281789 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 287
Study 34281789 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary energy intake
Number of subjects: 287
Study 32687088 — intervention group
Group type: EXPERIMENTAL
Intervention: Miniaturized cardiopulmonary bypass (MCPB)
Number of subjects: 71
Study 32687088 — intervention group
Group type: COMPARATOR
Intervention: Conventional cardiopulmonary bypass (CCPB)
Number of subjects: 71
Study 32687088 — intervention group
Group type: COMPARATOR
Intervention: CCPB
Number of subjects: 71
Study 32687088 — intervention group
Group type: EXPERIMENTAL
Intervention: MCPB
Number of subjects: 71
Study 32687088 — intervention group
Group type: EXPERIMENTAL
Intervention: MCPB and CCPB
Number of subjects: 71
Study 35555631 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning mindfulness meditation (24 minutes)
Number of subjects: 16
Study 35555631 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening mindfulness meditation (24 minutes)
Number of subjects: 16
Study 35555631 — intervention group
Group type: COMPARATOR
Intervention: Both morning and evening meditation
Number of subjects: 16
Study 33140403 — intervention group
Group type: EXPERIMENTAL
Intervention: MDZ‐NS 5 mg
Number of subjects: 62
Study 33140403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 34226609 — intervention group
Group type: EXPERIMENTAL
Intervention: Fertilization
Number of subjects: 0
Study 33897217 — intervention group
Group type: EXPERIMENTAL
Intervention: Community perception and attitude towards people with depression
Number of subjects: 617
Study 33897217 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred treatment for people with depression
Number of subjects: 617
Study 33897217 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors affecting community attitude
Number of subjects: 617
Study 35468580 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 IU/day of cholecalciferol (vitamin D3) for 14 days
Number of subjects: 0
Study 35468580 — intervention group
Group type: COMPARATOR
Intervention: 2000 IU/day of cholecalciferol (vitamin D3) for 14 days
Number of subjects: 0
Study 34281611 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Extremity Constraint-Induced Movement Therapy (LE-CIT) for 2.5 h/day for 15 consecutive days, including intensive supervised training, shaping strategy for motor training, and a transfer package (plus 30 min).
Number of subjects: 42
Study 34281611 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy for 2.5 h/day for 15 consecutive days.
Number of subjects: 42
Study 36055581 — intervention group
Group type: EXPERIMENTAL
Intervention: Meals delivered multiple times per week by a Meals on Wheels volunteer or paid driver who may socialize with and provide an informal wellness check
Number of subjects: 236
Study 36055581 — intervention group
Group type: COMPARATOR
Intervention: Frozen meals that are mailed to participants' homes every two weeks
Number of subjects: 236
Study 33624407 — intervention group
Group type: COMPARATOR
Intervention: Principal stratum strategy
Number of subjects: 0
Study 33624407 — intervention group
Group type: COMPARATOR
Intervention: ICH E9(R1) estimand framework
Number of subjects: 0
Study 33151151 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform only (24-week behavior change program with personalized computer-delivered feedback)
Number of subjects: 1298
Study 33151151 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform plus coaching (24-week behavior change program plus 12 weeks of personalized feedback by a dietitian)
Number of subjects: 1298
Study 33151151 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (nonpersonalized dietary and physical activity recommendations)
Number of subjects: 1298
Study 33151151 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform only
Number of subjects: 1298
Study 33151151 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform plus coaching
Number of subjects: 1298
Study 33151151 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 1298
Study 33151151 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer usage of the platform
Number of subjects: 1298
Study 36359533 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy in the cervical spine and diaphragm, in combination with breathing reeducation exercises
Number of subjects: 0
Study 36359533 — intervention group
Group type: COMPARATOR
Intervention: Cervical spine manual therapy or usual physical therapy care
Number of subjects: 0
Study 32712663 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive therapy (PET) with valganciclovir for 100 days
Number of subjects: 205
Study 32712663 — intervention group
Group type: COMPARATOR
Intervention: Prophylaxis with valganciclovir for 100 days
Number of subjects: 205
Study 32712663 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive therapy (PET)
Number of subjects: 205
Study 32712663 — intervention group
Group type: COMPARATOR
Intervention: Prophylaxis
Number of subjects: 205
Study 32697707 — intervention group
Group type: COMPARATOR
Intervention: ECT (n = 13)
Number of subjects: 25
Study 32697707 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg over 45 min; n = 12)
Number of subjects: 25
Study 35120457 — intervention group
Group type: EXPERIMENTAL
Intervention: Aging, Community and Health Research Unit-Community Partnership Program (ACHRU-CPP)
Number of subjects: 0
Study 35120457 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 33962520 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist girth (centimeters)
Number of subjects: 220
Study 33962520 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle plantar flexor strength (kilograms)
Number of subjects: 220
Study 33962520 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain at multiple sites (pain at 1 other site)
Number of subjects: 220
Study 33962520 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain at multiple sites (pain at 4 or more other sites)
Number of subjects: 220
Study 33962520 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain catastrophizing status (some)
Number of subjects: 220
Study 33962520 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain catastrophizing status (catastrophizer)
Number of subjects: 220
Study 34859602 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified mobile health intervention (mobile game designed for children)
Number of subjects: 124
Study 34859602 — intervention group
Group type: COMPARATOR
Intervention: Routine care with mobile game
Number of subjects: 124
Study 35183768 — intervention group
Group type: COMPARATOR
Intervention: HRWLE with Seattle protocol biopsies
Number of subjects: 154
Study 35183768 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-biomarker panel (pCLE optical dysplasia, aberrant p53, aneuploidy)
Number of subjects: 154
Study 33406353 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma with high IgG titers
Number of subjects: 160
Study 33406353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 33406353 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma with high IgG titers (modified intention-to-treat analysis)
Number of subjects: 160
Study 35511610 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish intake
Number of subjects: 32
Study 35511610 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat intake
Number of subjects: 32
Study 35511610 — intervention group
Group type: COMPARATOR
Intervention: Sugar-sweetened beverages (SSBs) intake
Number of subjects: 32
Study 35511610 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma NIRLeucine
Number of subjects: 32
Study 35511610 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma NIRGlutamic acid/glutamine
Number of subjects: 32
Study 35511610 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma NIRProline
Number of subjects: 32
Study 35511610 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC NIRProline
Number of subjects: 32
Study 36474770 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg S201086/GLPG1972
Number of subjects: 852
Study 36474770 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg S201086/GLPG1972
Number of subjects: 852
Study 36474770 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg S201086/GLPG1972
Number of subjects: 852
Study 36474770 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 852
Study 34414430 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 666
Study 34414430 — intervention group
Group type: COMPARATOR
Intervention: Beta blockers
Number of subjects: 666
Study 34414430 — intervention group
Group type: COMPARATOR
Intervention: No rate control drugs
Number of subjects: 666
Study 33950868 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior approach injection (54 patients)
Number of subjects: 95
Study 33950868 — intervention group
Group type: COMPARATOR
Intervention: Posterior approach injection (41 patients)
Number of subjects: 95
Study 32445609 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 3 cmH2 O without recruitment maneuver
Number of subjects: 57
Study 32445609 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 3 cmH2 O with recruitment maneuver
Number of subjects: 57
Study 32445609 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 7 cmH2 O without recruitment maneuver
Number of subjects: 57
Study 32445609 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 7 cmH2 O with recruitment maneuver
Number of subjects: 57
Study 34652088 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Aerobic (CA) exercise
Number of subjects: 30
Study 34652088 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval Aerobic (IA) exercise
Number of subjects: 30
Study 34652088 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance (RE) exercise
Number of subjects: 30
Study 34652088 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 30
Study 34510814 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist (degarelix)
Number of subjects: 0
Study 34510814 — intervention group
Group type: COMPARATOR
Intervention: GnRH agonist (leuprorelin acetate or goserelin acetate)
Number of subjects: 0
Study 33162294 — intervention group
Group type: EXPERIMENTAL
Intervention: Slope-configured implants (test group)
Number of subjects: 19
Study 33162294 — intervention group
Group type: COMPARATOR
Intervention: Regular-configured implants (control group)
Number of subjects: 19
Study 33162294 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjacent teeth (GCF biomarkers)
Number of subjects: 19
Study 32925729 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve block (FNB)
Number of subjects: 200
Study 32925729 — intervention group
Group type: COMPARATOR
Intervention: Obturator nerve block (ONB)
Number of subjects: 200
Study 32925729 — intervention group
Group type: EXPERIMENTAL
Intervention: FNB
Number of subjects: 200
Study 32925729 — intervention group
Group type: COMPARATOR
Intervention: ONB
Number of subjects: 200
Study 36483124 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modification (LM) intervention for 4 months
Number of subjects: 28
Study 36483124 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful self-compassion (MSC) training for 2 months
Number of subjects: 28
Study 36483124 — intervention group
Group type: COMPARATOR
Intervention: Control group (cooking/dietary education)
Number of subjects: 28
Study 33952329 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning using total occlusion pressure
Number of subjects: 80
Study 33952329 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning with 40% more than total occlusion pressure
Number of subjects: 80
Study 33952329 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10 mmHg)
Number of subjects: 80
Study 33952329 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study 35781462 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‰ PL‐5 spray
Number of subjects: 220
Study 35781462 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‰ PL‐5 spray
Number of subjects: 220
Study 35781462 — intervention group
Group type: EXPERIMENTAL
Intervention: 4‰ PL‐5 spray
Number of subjects: 220
Study 35781462 — intervention group
Group type: COMPARATOR
Intervention: Control group (silver sulfadiazine)
Number of subjects: 220